Tag Archives: CATB

Best Safest Stocks To Own For 2019

Mark Carney may be wondering at times if less is more when he speaks to financial markets.

After a bruising month that’s seen his own signals on interest rates questioned and one of his deputies forced to apologize for calling the economy menopausal, communication is once again a hot topic for the Bank of England governor.

Carney, who arrived at the BOE in 2013 with forward guidance as his signature policy, will come under more scrutiny this week when he faces a grilling from U.K. lawmakers. He’ll also give speeches in London and Stockholm.

“Some people would say the safest thing for the Bank of England to do right now is to go back to being mystical,” said Clea Bourne, a senior lecturer and financial communications specialist at Goldsmiths, University of London.

Communication dominated Carney’s press conference following the BOE’s May 10 policy announcement, and will doubtless figure in Tuesday’s session in Parliament. Carney and his colleagues will be questioned on the decision, which saw officials hold off on a rate hike that had been seen as a certainty just weeks earlier. Brexit and its impact on the economy will also probably feature at the hearing.

Best Safest Stocks To Own For 2019: Pagegroup PLC (PAGE)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Pagegroup (LON:PAGE) had its target price reduced by Royal Bank of Canada from GBX 670 ($8.75) to GBX 620 ($8.10) in a note issued to investors on Monday. The firm presently has an “outperform” rating on the stock. Royal Bank of Canada’s price target would indicate a potential upside of 30.86% from the stock’s current price.

  • [By Max Byerly]

    Pagegroup (LON:PAGE) had its target price raised by UBS Group from GBX 550 ($7.09) to GBX 600 ($7.74) in a report released on Monday, investing.thisismoney.co.uk reports. They currently have a neutral rating on the stock.

  • [By Ethan Ryder]

    Pagegroup PLC (LON:PAGE) declared a dividend on Wednesday, August 8th, Upcoming.Co.Uk reports. Stockholders of record on Thursday, September 6th will be paid a dividend of GBX 16.83 ($0.22) per share on Wednesday, October 10th. This represents a dividend yield of 2.81%. The ex-dividend date is Thursday, September 6th. This is a positive change from Pagegroup’s previous dividend of $8.60. The official announcement can be accessed at this link.

  • [By Logan Wallace]

    Pagegroup (LON:PAGE) was upgraded by stock analysts at Liberum Capital to a “buy” rating in a note issued to investors on Wednesday.

    PAGE has been the subject of a number of other research reports. UBS Group reissued a “neutral” rating on shares of Pagegroup in a report on Wednesday, January 2nd. Royal Bank of Canada reissued an “outperform” rating on shares of Pagegroup in a report on Thursday, January 10th. HSBC dropped their price objective on shares of Pagegroup from GBX 700 ($9.15) to GBX 675 ($8.82) and set a “buy” rating for the company in a report on Monday, January 7th. Finally, Jefferies Financial Group dropped their price objective on shares of Pagegroup from GBX 620 ($8.10) to GBX 610 ($7.97) and set a “buy” rating for the company in a report on Tuesday, January 15th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of GBX 578.62 ($7.56).

Best Safest Stocks To Own For 2019: Catabasis Pharmaceuticals, Inc.(CATB)

Advisors’ Opinion:

  • [By Shane Hupp]

    Catabasis Pharmaceuticals Inc (NASDAQ:CATB) traded down 7.2% during trading on Wednesday . The company traded as low as $0.63 and last traded at $0.64. 738,517 shares traded hands during trading, a decline of 6% from the average session volume of 787,009 shares. The stock had previously closed at $0.69.

  • [By Ethan Ryder]

    Press coverage about Catabasis Pharmaceuticals (NASDAQ:CATB) has been trending somewhat positive recently, according to Accern. The research firm identifies negative and positive press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Catabasis Pharmaceuticals earned a media sentiment score of 0.05 on Accern’s scale. Accern also assigned news articles about the biotechnology company an impact score of 44.9364257314523 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

  • [By Shane Hupp]

    Shares of Catabasis Pharmaceuticals Inc (NASDAQ:CATB) have earned an average recommendation of “Buy” from the seven research firms that are currently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $3.54.

Best Safest Stocks To Own For 2019: Match Group, Inc.(MTCH)

Advisors’ Opinion:

  • [By Chris Lange]

    Match Group Inc. (NASDAQ: MTCH) saw its short interest fall to 27.85 million from the previous 29.16 million. Shares were trading at $45.26, in a 52-week range of $16.57 to $48.65.

  • [By Chris Lange]

    Match Group Inc. (NASDAQ: MTCH) saw its short interest decrease to 24.74 million from the previous 25.07 million. Shares were trading at $58.19, in a 52-week range of $23.16 to $60.95.

  • [By ]

    The Match Group-owned (Nasdaq: MTCH) app popularized the “swipe-based, double-blind, opt-in” method of online dating, meaning users pre-select each other to form a match, rather than just sending a message on a platform without prior hint of interest.

  • [By Ethan Ryder]

    HealthStream (NASDAQ: MTCH) and Match Group (NASDAQ:MTCH) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, analyst recommendations and risk.

Best Safest Stocks To Own For 2019: Portland General Electric Company(POR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Portland General Electric (NYSE:POR) and RED ELECTRICA C/ADR (OTCMKTS:RDEIY) are both utilities companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

  • [By Shane Hupp]

    Mizuho reiterated their buy rating on shares of Portland General Electric (NYSE:POR) in a research report report published on Thursday. They currently have a $50.00 price target on the utilities provider’s stock.

  • [By Logan Wallace]

    ValuEngine upgraded shares of Portland General Electric (NYSE:POR) from a sell rating to a hold rating in a report issued on Friday.

    Several other equities research analysts also recently commented on POR. Guggenheim reiterated a hold rating and set a $40.00 target price on shares of Portland General Electric in a research report on Friday, February 23rd. Bank of America downgraded shares of Portland General Electric from a neutral rating to an underperform rating and cut their target price for the stock from $41.00 to $39.00 in a research report on Tuesday, March 6th. JPMorgan Chase & Co. cut their target price on shares of Portland General Electric from $42.00 to $41.00 and set a neutral rating on the stock in a research report on Tuesday, March 27th. Finally, Zacks Investment Research upgraded shares of Portland General Electric from a sell rating to a hold rating in a research report on Wednesday, May 2nd. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company. The stock has an average rating of Hold and a consensus target price of $42.44.

  • [By Motley Fool Transcribers]

    Portland General Electric Co  (NYSE:POR)Q4 2018 Earnings Conference CallFeb. 15, 2019, 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 5 Safest Stocks To Buy For 2019

1. Blame the bonds: The normally boring bond market is causing serious drama on Wall Street.

An avalanche of selling sent the Dow and S&P 500 careening 5% lower last week, one of the stock market’s worst weeks since the 2008 financial crisis.

The culprit: Rapidly rising bond yields are alarming investors who got hooked on a decade of low interest rates.

So what’s going on here? And why the focus on the bond market?

Modern financial markets function on the belief that U.S. government debt is the safest investment on the planet.

Knowing how much they can earn from “risk-free” Treasury bonds allows investors to determine the cost of stocks and other riskier assets. Treasuries serve as the benchmark for all other forms of credit, from junk bonds to mortgages.

“The 10-year Treasury sets the price for every asset in the world,” said Brent Schutte, chief investment strategist at Northwestern Mutual.

That means the surge in the 10-year yield — from 2.4% earlier this year to about 2.8% now — has increased the cost of money generally.

Top 5 Safest Stocks To Buy For 2019: Catabasis Pharmaceuticals, Inc.(CATB)

Advisors’ Opinion:

  • [By Max Byerly]

    Press coverage about Catabasis Pharmaceuticals (NASDAQ:CATB) has been trending somewhat positive recently, Accern reports. The research firm identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Catabasis Pharmaceuticals earned a media sentiment score of 0.14 on Accern’s scale. Accern also gave press coverage about the biotechnology company an impact score of 47.6345851568851 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Shane Hupp]

    Catabasis Pharmaceuticals Inc (NASDAQ:CATB) traded down 7.2% during trading on Wednesday . The company traded as low as $0.63 and last traded at $0.64. 738,517 shares traded hands during trading, a decline of 6% from the average session volume of 787,009 shares. The stock had previously closed at $0.69.

  • [By Ethan Ryder]

    Press coverage about Catabasis Pharmaceuticals (NASDAQ:CATB) has been trending somewhat positive recently, according to Accern. The research firm identifies negative and positive press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Catabasis Pharmaceuticals earned a media sentiment score of 0.05 on Accern’s scale. Accern also assigned news articles about the biotechnology company an impact score of 44.9364257314523 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

  • [By Max Byerly]

    These are some of the news articles that may have effected Accern’s analysis:

    Get Catabasis Pharmaceuticals alerts:

    Market Trends Toward New Normal in Church & Dwight Co., Rent-A-Center, Teradata, Catabasis Pharmaceuticals, Tronox, and Callaway Golf — Emerging Consolidated Expectations, Analyst Ratings (finance.yahoo.com) Catabasis Pharmaceuticals Inc. – Receive News & Ratings Daily (thecasualsmart.com) Catabasis Pharmaceuticals (CATB) Upgraded by ValuEngine to Sell (americanbankingnews.com) Catabasis Pharmaceuticals to Report First Quarter 2018 Financial Results and Recent Corporate Developments on Thursday, May 10 (finance.yahoo.com) Catabasis Pharmaceuticals Inc (CATB) Given Consensus Rating of “Buy” by Brokerages (americanbankingnews.com)

    A number of analysts recently issued reports on CATB shares. Zacks Investment Research raised Catabasis Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Friday, January 26th. Wedbush reaffirmed an “outperform” rating and issued a $4.00 target price (down previously from $5.00) on shares of Catabasis Pharmaceuticals in a research report on Wednesday, February 14th. Finally, ValuEngine raised Catabasis Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research report on Wednesday, May 2nd. One analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the stock. Catabasis Pharmaceuticals presently has a consensus rating of “Buy” and a consensus target price of $5.18.

Top 5 Safest Stocks To Buy For 2019: Carnival Corporation(CCL)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    This is how you could make an easy 100% in the weeks ahead.

    Four Stocks to Watch Today: CCL, HOG, GE, AMZN
    Harley Davidson (NYSE: HOG) has weighed in on U.S. trade policy. The company said over the weekend that European Union tariffs could fuel an uptick in prices by at least $2,200 per unit. However, the company said in a statement that it does not plan to raise prices as a result. Instead, the firm plans to shift its production intended for EU sales out of the United States.
    General Electric (NYSE: GE) is on the verge of selling its industrial division to private equity giant Advent Capital for $3 billion. According to reports, Advent beat out Cummins in a bidding war for the lucrative industrial engine group.
    Amazon.com Inc. (Nasdaq: AMZN) is ramping up its Prime grocery store sales. The company’s Whole Foods savings program has expanded nationwide. After a brief trial period in Florida, Prime members can now access deals in every state. It’s bad news for grocery rivals as Amazon continues to expand.
    Look for an earnings report from Carnival Corp. (NYSE: CCL). Wall Street analysts project that the cruise line will report earnings per share (EPS) of $0.60 on top of $4.33 billion in revenue.
    This Man Can Show You How to Make Money in ANY Market – Bull, Bear, or Sideways

    This champion stock picker first gave his readers the chance at fortunes during a huge market crash – Black Monday, August 2011, when the United States’ credit rating was downgraded for the first time in history.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Carnival (CCL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Demitrios Kalogeropoulos]

    With that idea in mind, below I’ll take a look at a few stocks that have missed at least part of the recent rally but still look like strong long-term investments. Read on to find out why Carnival (NYSE:CCL), Procter & Gamble (NYSE:PG), and eBay (NASDAQ:EBAY) might be cheap right now for the wrong reasons.

  • [By Demitrios Kalogeropoulos]

    There’s no sign of rough seas ahead in the cruise ship industry. Instead, Carnival (NYSE:CCL) just announced fiscal second-quarter earnings results that sailed past management’s guidance for the second straight quarter.

Top 5 Safest Stocks To Buy For 2019: Bruker Corporation(BRKR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Bruker Co. (NASDAQ:BRKR) – Jefferies Financial Group lowered their Q1 2019 earnings per share (EPS) estimates for Bruker in a research report issued on Tuesday, February 12th. Jefferies Financial Group analyst B. Couillard now expects that the medical research company will earn $0.24 per share for the quarter, down from their previous forecast of $0.28. Jefferies Financial Group also issued estimates for Bruker’s Q3 2019 earnings at $0.42 EPS, Q4 2019 earnings at $0.60 EPS, FY2019 earnings at $1.58 EPS and FY2020 earnings at $1.75 EPS.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Bruker (BRKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Shares of Bruker Co. (NASDAQ:BRKR) have received a consensus rating of “Hold” from the twelve brokerages that are presently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and three have issued a buy recommendation on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $33.11.

Top 5 Safest Stocks To Buy For 2019: Preferred Bank(PFBC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Preferred Bank (PFBC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Sei Investments Co. decreased its position in shares of Preferred Bank (NASDAQ:PFBC) by 10.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,114 shares of the bank’s stock after selling 1,803 shares during the quarter. Sei Investments Co.’s holdings in Preferred Bank were worth $970,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Preferred Bank (PFBC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Preferred Bank (PFBC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Preferred Bank (PFBC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Safest Stocks To Buy For 2019: TRACON Pharmaceuticals, Inc.(TCON)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on TRACON Pharmaceuticals (TCON)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    TRACON Pharmaceuticals Inc (NASDAQ:TCON) fell 12.3% during trading on Wednesday . The company traded as low as $1.23 and last traded at $1.21. 896,880 shares changed hands during trading, an increase of 112% from the average session volume of 422,831 shares. The stock had previously closed at $1.38.

Hot Low Price Stocks To Own Right Now

Being a member of the esteemed Dow Jones industrial average index is supposed to come with prestige. After all, there are only 30 companies at a time that can actually be a Dow stock. These companies are supposed to represent a major portion of the industrial business climate or to dominate a major component of the economy in America.

General Electric Co. (NYSE: GE) has been the longest lasting member of the Dow’s original components, but now the prior rumors and ponderings about GE being ejected from the Dow have finally come true. GE is being replaced by Walgreens Boots Alliance Inc. (NASDAQ: WBA) effective prior to the open of trading on Tuesday, June 26.

It is no secret that GE has been troubled for quite some time. After too many acquisitions and divestitures to easily count, and selling for low prices while paying high prices, General Electric has lost its way. To many investors, it may now look and feel more like “General Eclectic.”

Hot Low Price Stocks To Own Right Now: Piper Jaffray Companies(PJC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    These are some of the media headlines that may have impacted Accern Sentiment’s scoring:

    Get Piper Jaffray Companies alerts:

    Financials still look pretty bleak after snapping their worst losing streak on record (cnbc.com) Buy Apple-supplier Lumentum because demand for its 3D sensors will surge: Piper (cnbc.com) Reviewing Piper Jaffray Companies (PJC) & Cowen Inc Class A (COWN) (americanbankingnews.com) Exclusive: These four San Francisco Bay Area stocks doubled in the first half of 2018, and here's why (finance.yahoo.com) Piper Jaffray and Kepler Cheuvreux Announce Extension of Equity Research Distribution Agreement to Switzerland (finance.yahoo.com)

    NYSE:PJC traded down $1.05 during mid-day trading on Wednesday, hitting $76.40. The stock had a trading volume of 37,147 shares, compared to its average volume of 88,276. The company has a market cap of $1.18 billion, a PE ratio of 11.54 and a beta of 1.53. Piper Jaffray Companies has a 52 week low of $52.75 and a 52 week high of $99.80. The company has a quick ratio of 0.10, a current ratio of 1.54 and a debt-to-equity ratio of 0.17.

  • [By Max Byerly]

    Charles Schwab Co. Common Stock (NYSE: PJC) and Piper Jaffray Companies (NYSE:PJC) are both finance companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, profitability, risk, institutional ownership and valuation.

Hot Low Price Stocks To Own Right Now: Catabasis Pharmaceuticals, Inc.(CATB)

Advisors’ Opinion:

  • [By Max Byerly]

    Press coverage about Catabasis Pharmaceuticals (NASDAQ:CATB) has been trending somewhat positive recently, Accern reports. The research firm identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Catabasis Pharmaceuticals earned a media sentiment score of 0.14 on Accern’s scale. Accern also gave press coverage about the biotechnology company an impact score of 47.6345851568851 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Max Byerly]

    These are some of the news articles that may have effected Accern’s analysis:

    Get Catabasis Pharmaceuticals alerts:

    Market Trends Toward New Normal in Church & Dwight Co., Rent-A-Center, Teradata, Catabasis Pharmaceuticals, Tronox, and Callaway Golf — Emerging Consolidated Expectations, Analyst Ratings (finance.yahoo.com) Catabasis Pharmaceuticals Inc. – Receive News & Ratings Daily (thecasualsmart.com) Catabasis Pharmaceuticals (CATB) Upgraded by ValuEngine to Sell (americanbankingnews.com) Catabasis Pharmaceuticals to Report First Quarter 2018 Financial Results and Recent Corporate Developments on Thursday, May 10 (finance.yahoo.com) Catabasis Pharmaceuticals Inc (CATB) Given Consensus Rating of “Buy” by Brokerages (americanbankingnews.com)

    A number of analysts recently issued reports on CATB shares. Zacks Investment Research raised Catabasis Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Friday, January 26th. Wedbush reaffirmed an “outperform” rating and issued a $4.00 target price (down previously from $5.00) on shares of Catabasis Pharmaceuticals in a research report on Wednesday, February 14th. Finally, ValuEngine raised Catabasis Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research report on Wednesday, May 2nd. One analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the stock. Catabasis Pharmaceuticals presently has a consensus rating of “Buy” and a consensus target price of $5.18.

  • [By Shane Hupp]

    Catabasis Pharmaceuticals Inc (NASDAQ:CATB) traded down 7.2% during trading on Wednesday . The company traded as low as $0.63 and last traded at $0.64. 738,517 shares traded hands during trading, a decline of 6% from the average session volume of 787,009 shares. The stock had previously closed at $0.69.

  • [By Shane Hupp]

    Shares of Catabasis Pharmaceuticals Inc (NASDAQ:CATB) have earned an average recommendation of “Buy” from the seven research firms that are currently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $3.54.

Hot Low Price Stocks To Own Right Now: SoftBank Group Corp. (SFTBY)

Advisors’ Opinion:

  • [By ]

    Deutsche Telekom will hold 42% of the equity, with Softbank (SFTBY) owning 27% and the remaining 31% to be held by public investors. The new company will take on the T-Mobile name.

  • [By SEEKINGALPHA.COM]

    The largest part of the valuation puzzle regarding NTT is NTT DoCoMo (NYSE:DCM), Japan’s largest telecommunications company with 73 million customers and a market share of 46%. Its primary competitors are KDDI (OTCPK:KDDIF) with 30% share and Softbank (OTCPK:SFTBY) with 24%. With only three main players, competition is limited and all players are profitable.

  • [By ]

    Canadian hard-rock lithium chemicals company Nemaska Lithium (OTCQX:NMKEF) is presently at the end of completing a $500 million capital raise which will allow the company to expand into Phase 2 production of the its facility in Quebec. The company has closed an equity deal valued at nearly $100 million from Japan’s SoftBank (OTCPK:SFTBY), executed a streaming agreement with Orion Mine Finance LF valued at over $150 million, and engaged with such high-quality financial groups including Clarkson Platou Securities and Pareto Securities as managers of the bond issuance. Further, Nemaska has signed multiple offtake agreements, including NorthVolt, FMC, Softbank and Johnson Matthey Battery Materials, for the purchase of its lithium chemicals once production begins.

  • [By Joseph Griffin]

    SoftBank Group Corp – (OTCMKTS:SFTBY) – Research analysts at Jefferies Financial Group issued their FY2019 EPS estimates for shares of SoftBank Group in a report released on Monday, August 27th. Jefferies Financial Group analyst A. Goyal expects that the technology company will post earnings per share of $5.97 for the year. Jefferies Financial Group also issued estimates for SoftBank Group’s FY2020 earnings at $6.62 EPS and FY2021 earnings at $8.39 EPS.

Hot Low Price Stocks To Own Right Now: NetSol Technologies Inc.(NTWK)

Advisors’ Opinion:

  • [By Stephan Byrd]

    TheStreet upgraded shares of NetSol Technologies (NASDAQ:NTWK) from a d+ rating to a c- rating in a research note published on Tuesday morning.

    Separately, ValuEngine raised shares of NetSol Technologies from a hold rating to a buy rating in a research report on Thursday, May 17th.

  • [By Ethan Ryder]

    NetSol Technologies (NASDAQ:NTWK) CEO Najeeb Ghauri purchased 2,500 shares of the business’s stock in a transaction on Friday, May 25th. The shares were acquired at an average cost of $6.20 per share, with a total value of $15,500.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

  • [By Lisa Levin] Gainers
    Precipio, Inc. (NASDAQ: PRPO) jumped 43.3 percent to $0.5447 after the micro-cap specialty diagnostics company reported preliminary first-quarter results. The company said its first quarter revenue rose 286 percent from the same quarter a year ago to $712,000.
    Galectin Therapeutics, Inc. (NASDAQ: GALT) gained 34.5 percent to $4.52 after the company announced it would proceed with Phase 3 development of GR-MD-02 for NASH Cirrhosis following the FDA meeting.
    Boxlight Corporation (NASDAQ: BOXL) shares rose 21.9 percent to $8.1063.
    Evolus, Inc. (NASDAQ: EOLS) shares surged 16 percent to $15.65.
    Myomo, Inc. (NYSE: MYO) shares jumped 15.5 percent to $3.6263 after the company disclosed that its application for Medicare codes received favorable preliminary decision.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) rose 13.7 percent to $10.12.
    ProPhase Labs, Inc. (NASDAQ: PRPH) gained 13.7 percent to $4.6743.
    Acacia Communications, Inc. (NASDAQ: ACIA) shares gained 12.2 percent to $35.34 as optical sector is seeing strength following President Trump's announcement that he would work with China related to ZTE Corp.
    Tailored Brands, Inc. (NYSE: TLRD) shares rose 11.3 percent to $35.17. Jefferies upgraded Tailored Brands from Hold to Buy.
    Kona Grill, Inc. (NASDAQ: KONA) jumped 10.6 percent to $2.875.
    Federated National Holding Company (NASDAQ: FNHC) shares rose 10.6 percent to $20.29. Raymond James upgraded Federated National Holding from Outperform to Strong Buy.
    Renewable Energy Group, Inc. (NASDAQ: REGI) climbed 10.2 percent to $15.15. Renewable Energy will replace Synchronoss Technologies Inc. (NASDAQ: SNCR) in the S&P SmallCap 600 on Tuesday, May 15.
    Stein Mart, Inc. (NASDAQ: SMRT) shares climbed 10.1 percent to $3.16. Stein Mart is expected to release Q1 earnings on May 23.
    NXP Semiconductors N.V. (NASDAQ: NXPI) rose 9.7 percent to $108.60 after Bloomberg reported that the China’s Commerce Ministry has restar
  • [By Logan Wallace]

    Sapiens International (NASDAQ: SPNS) and NetSol Technologies (NASDAQ:NTWK) are both small-cap computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.

  • [By Stephan Byrd]

    NetSol Technologies (NASDAQ:NTWK) CEO Najeeb Ghauri acquired 2,500 shares of NetSol Technologies stock in a transaction that occurred on Wednesday, May 30th. The stock was acquired at an average price of $6.50 per share, with a total value of $16,250.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Hot Medical Stocks To Invest In Right Now

Kudos to Merck & Co., Inc. (NYSE:MRK) and Pfizer Inc. (NYSE:PFE) for taking a leap forward in the war against diabetes. The two competitors-turned-partners for one joint venture recently announced the FDA and the European equivalent has accepted an application for permission to sell ertugliflozin and a couple of its derivatives. All the drugs/combos in question are part of the SGLT2 family, which essentially induce the kidneys to filter sugar out of the bloodstream for diabetics whose pancreas isn’t processing that sugar properly.

It’s an interesting approach, though not one without a potential downside. By forcing the kidneys to do something they weren’t meant to do, eventually, could pose new problems.

Cell MedX Corp (OTCMKTS:CMXC) is taking an entirely different approach to the treatment of diabetes. Rather than work around a failing pancreas as Merck and Pfizer have, Cell MedX is aiming to fix what’s broken for diabetics. That is, the company aims to restore a body’s cells that properly process sugar by turning them back “on” again using mild electrical currents.

As much as biologists and the healthcare industry know about the human body, new discoveries are being made all the time regarding our makeup. One of the more recent medical revelations was figuring out animals are not just a collection of chemicals and organic matter, but also electrical impulses. Yes, the human body creates electricity, but more than that, a body can benefit from mild electrical currents, as an electrical charge can put a damaged cell back into its natural, healthy state.

It may seem like a crazy idea at first, but know the FDA has already given the science of electromedicine the nod of approval as a treatment for chronic pain (called the Cefaly, if you’re curious), and some major companies are wading deeper into electromedicine waters.

As Scientific American’s Daisy Yuhas noted back in 2013:

Hot Medical Stocks To Invest In Right Now: Catabasis Pharmaceuticals, Inc.(CATB)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the news articles that may have effected Accern’s analysis:

    Get Catabasis Pharmaceuticals alerts:

    Market Trends Toward New Normal in Church & Dwight Co., Rent-A-Center, Teradata, Catabasis Pharmaceuticals, Tronox, and Callaway Golf Emerging Consolidated Expectations, Analyst Ratings (finance.yahoo.com) Catabasis Pharmaceuticals Inc. – Receive News & Ratings Daily (thecasualsmart.com) Catabasis Pharmaceuticals (CATB) Upgraded by ValuEngine to Sell (americanbankingnews.com) Catabasis Pharmaceuticals to Report First Quarter 2018 Financial Results and Recent Corporate Developments on Thursday, May 10 (finance.yahoo.com) Catabasis Pharmaceuticals Inc (CATB) Given Consensus Rating of “Buy” by Brokerages (americanbankingnews.com)

    A number of analysts recently issued reports on CATB shares. Zacks Investment Research raised Catabasis Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Friday, January 26th. Wedbush reaffirmed an “outperform” rating and issued a $4.00 target price (down previously from $5.00) on shares of Catabasis Pharmaceuticals in a research report on Wednesday, February 14th. Finally, ValuEngine raised Catabasis Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research report on Wednesday, May 2nd. One analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the stock. Catabasis Pharmaceuticals presently has a consensus rating of “Buy” and a consensus target price of $5.18.

Hot Medical Stocks To Invest In Right Now: Banner Corporation(BANR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the news articles that may have impacted Accern’s rankings:

    Get Banner alerts:

    Banner Year for Asset Managers Could Be Catalyst for Change (markets.financialcontent.com) Zacks: Analysts Anticipate Banner Co. (BANR) to Announce $0.86 EPS (americanbankingnews.com) Banner Bank signs long lease for highly visible Sacramento site (finance.yahoo.com) Steven W. Rust Sells 511 Shares of Banner Co. (BANR) Stock (americanbankingnews.com) FY2018 Earnings Estimate for Banner Co. (BANR) Issued By DA Davidson (americanbankingnews.com)

    NASDAQ BANR opened at $57.47 on Friday. The company has a quick ratio of 0.90, a current ratio of 0.92 and a debt-to-equity ratio of 0.24. The firm has a market cap of $1,896.48, a P/E ratio of 19.22, a PEG ratio of 1.66 and a beta of 0.96. Banner has a 1 year low of $52.07 and a 1 year high of $62.75.

Hot Medical Stocks To Invest In Right Now: Acacia Communications, Inc. (ACIA)

Advisors’ Opinion:

  • [By Leo Sun]

    That ban would cripple China’s 5G expansion efforts, since ZTE needs components from American companies like Acacia Communications (NASDAQ:ACIA) and Qualcomm. ZTE uses Acacia’s fiber optic components in its infrastructure upgrades, and Qualcomm’s SoCs in its smartphones.

  • [By Benzinga News Desk]

    President Donald Trump hinted he may intervene in the Justice Department’s Russia investigation, as a Senate panel advanced a measure to protect Special Counsel Robert Mueller: Link

    ECONOMIC DATA
    USA GDP (QoQ) for Q1 2.30% vs 2.00% Est; Prior 2.90%
    The University of Michigan's consumer confidence index for April is schedule for release at 10:00 a.m. ET.
    The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET.
    Data on farm prices for the recent week will be released at 3:00 p.m. ET.
    ANALYST RATINGS
    Stifel upgraded Facebook (NASDAQ: FB) from Hold to Buy
    Morgan Stanley upgraded Acacia Communications (NASDAQ: ACIA) from Underweight to Equal-Weight
    Jefferies downgraded Sunoco (NYSE: SUN) from Hold to Underperform
    KBW downgraded Oaktree Capital (NYSE: OAK) from Outperform to Market Perform

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

  • [By Lisa Levin] Gainers
    Precipio, Inc. (NASDAQ: PRPO) jumped 43.3 percent to $0.5447 after the micro-cap specialty diagnostics company reported preliminary first-quarter results. The company said its first quarter revenue rose 286 percent from the same quarter a year ago to $712,000.
    Galectin Therapeutics, Inc. (NASDAQ: GALT) gained 34.5 percent to $4.52 after the company announced it would proceed with Phase 3 development of GR-MD-02 for NASH Cirrhosis following the FDA meeting.
    Boxlight Corporation (NASDAQ: BOXL) shares rose 21.9 percent to $8.1063.
    Evolus, Inc. (NASDAQ: EOLS) shares surged 16 percent to $15.65.
    Myomo, Inc. (NYSE: MYO) shares jumped 15.5 percent to $3.6263 after the company disclosed that its application for Medicare codes received favorable preliminary decision.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) rose 13.7 percent to $10.12.
    ProPhase Labs, Inc. (NASDAQ: PRPH) gained 13.7 percent to $4.6743.
    Acacia Communications, Inc. (NASDAQ: ACIA) shares gained 12.2 percent to $35.34 as optical sector is seeing strength following President Trump's announcement that he would work with China related to ZTE Corp.
    Tailored Brands, Inc. (NYSE: TLRD) shares rose 11.3 percent to $35.17. Jefferies upgraded Tailored Brands from Hold to Buy.
    Kona Grill, Inc. (NASDAQ: KONA) jumped 10.6 percent to $2.875.
    Federated National Holding Company (NASDAQ: FNHC) shares rose 10.6 percent to $20.29. Raymond James upgraded Federated National Holding from Outperform to Strong Buy.
    Renewable Energy Group, Inc. (NASDAQ: REGI) climbed 10.2 percent to $15.15. Renewable Energy will replace Synchronoss Technologies Inc. (NASDAQ: SNCR) in the S&P SmallCap 600 on Tuesday, May 15.
    Stein Mart, Inc. (NASDAQ: SMRT) shares climbed 10.1 percent to $3.16. Stein Mart is expected to release Q1 earnings on May 23.
    NXP Semiconductors N.V. (NASDAQ: NXPI) rose 9.7 percent to $108.60 after Bloomberg reported that the China’s Commerce Ministry has restar

Hot Medical Stocks To Invest In Right Now: MarineMax, Inc.(HZO)

Advisors’ Opinion:

  • [By Lisa Levin]

    MarineMax, Inc. (NYSE: HZO) shares were also up, gaining 24 percent to $21.70 as the company posted upbeat Q2 results and raised its FY18 outlook.

    Equities Trading DOWN

  • [By Max Byerly]

    MarineMax, Inc. (NYSE:HZO) EVP Charles A. Cashman sold 25,000 shares of the business’s stock in a transaction dated Monday, May 7th. The stock was sold at an average price of $22.92, for a total value of $573,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

  • [By Lisa Levin]

    MarineMax, Inc. (NYSE: HZO) shares were also up, gaining 24 percent to $21.75 as the company posted upbeat Q2 results and raised its FY18 outlook.

    Equities Trading DOWN

Top Performing Stocks To Own Right Now

Corbus Pharmaceuticals (NASDAQ:CRBP) managed to become one of the top-performing biotech stocks on the market in 2016. Over the last 12 months, Corbus’ share price has soared 550%.

It was a bumpy ride for shareholders, though. Corbus stock had some big drops along the way, most recently falling around 25% before clawing its way back. How high can Corbus stock go from here?

Image source: Getty Images.

The main story for Corbus

There’s one driving factor behind Corbus’ success thus far: JBT-101 (also known as resunab). Thenovel synthetic oral endocannabinoid-mimetic drug is being evaluated in four clinical studies.

Corbus announced positive results in November from a phase 2 study of JBT-101 in treating systemic sclerosis, a chronic autoimmune rheumatic disease. Patients receiving the experimental drug achieved a medianCombined Response Index in diffuse cutaneous Systemic Sclerosis (CRISS) score of 33% at week 16 of treatment. Patients in the placebo group scored 0%.CRISS scores above 20% are considered to be meaningful improvement.

Top Performing Stocks To Own Right Now: Cal-Maine Foods, Inc.(CALM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cal-Maine Foods Inc (NASDAQ: CALM) posted in-line loss for its second quarter, but sales missed expectations.

    Cal-Maine Foods reported a Q2 loss of $0.48 per share on revenue of $253.5 million. Analysts were expecting a loss of $0.48 per share on revenue of $262.8 million.

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian said that Cal-Maine Foods Inc (NASDAQ: CALM) had unusually high options volume on Friday. Traders were buying the May 45 calls and Jon Najarian decided to follow the trade. He is planning to hold the position for 1 to 2 months.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Rite Aid Corporation (NYSE: RAD) to report quarterly earnings at $0.04 per share on revenue of $8.23 billion before the opening bell. Rite Aid shares gained 0.83 percent to $8.54 in after-hours trading.
    Micron Technology, Inc. (NASDAQ: MU) reported better-than-expected profit for its first quarter and issued a strong forecast for the current quarter. Micron shares climbed 9.91 percent to $22.62 in the after-hours trading session.
    Analysts expect Cal-Maine Foods Inc (NASDAQ: CALM) to post quarterly earnings at $0.48 per share on revenue of $262.83 million after the closing bell. Cal-Maine shares rose 0.12 percent to $42.75 in after-hours trading.
    Red Hat Inc (NYSE: RHT) reported upbeat earnings for its third quarter, but sales missed expectations. The company also announced that its CFO Frank Calderoni is stepping down. Red Hat shares tumbled 10.15 percent to $71.69 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Ben Levisohn]

    Cal-Maine Foods (CALM) has tumbled 6.3% to $35.00 after missing earnings forecasts.

    EXACT Sciences (EXAS) after its Cologard test was‘considered medically necessary every 3 years’ byAetna (AET). Aetna is unchanged at$126.77.

  • [By Tyler Crowe, Jordan Wathen, and Beth McKenna]

    So we asked three of our contributors to highlight a stock they see as a real underdog in the market today and why investors should be watching this stock. Here’s a quick look into why they picked banker Wells Fargo (NYSE:WFC), railcar manufacturer Greenbrier Companies (NYSE:GBX) , and egg wholesaler Cal-Maine Foods (NASDAQ:CALM)

Top Performing Stocks To Own Right Now: Interactive Brokers Group, Inc.(IBKR)

Advisors’ Opinion:

  • [By Travis Hoium]

    The ups and downs of revenue and earnings atInteractive Brokers Group, Inc. (NASDAQ:IBKR)struck again in the first quarter of 2017. Trading and market making were down versus a year before,but the company still reported a profit and is making long-term adjustments that could make the business more profitable for investors.

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than

Top Performing Stocks To Own Right Now: Catabasis Pharmaceuticals, Inc.(CATB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Catabasis Pharmaceuticals Inc (NASDAQ: CATB) got a boost, shooting up 46 percent to $6.52. Catabasis Pharmaceuticals and Sarepta Therapeutics Inc (NASDAQ: SRPT) reported a joint research collaboration in Duchenne Muscular Dystrophy.

Top Performing Stocks To Own Right Now: CIENA Corporation(CIEN)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Wednesday was a mixed day for the stock market, with the Dow Jones Industrials falling while the Nasdaq Composite posted modest gains. Parts of the market reacted differently to conflicting news items, which included both poor performance in the energy market and signs of promise for the economy more broadly. Despite the conflict among industry sectors, some stocks got hit particularly hard, and Rite Aid (NYSE:RAD), Ciena (NYSE:CIEN), and Express (NYSE:EXPR) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Lisa Levin]

    Ciena Corporation (NYSE: CIEN) posted downbeat earnings for its fourth quarter.

    Ciena posted Q4 adjusted earnings of $0.44 per share on revenue of $716.2 million. Analysts were expecting earnings of $0.46 per share on revenue of $716.5 million.

  • [By Trey Thoelcke]

    Ciena Corp. (NYSE: CIEN) will report its most recent quarterly results Thursday morning. The consensus estimates call for EPS of $0.49 and $726.84 million in revenue. Shares closed at $23.87 on Friday, in a 52-week range of $18.94 to $27.98. The consensus price target is $30.77.

Top 10 Heal Care Stocks To Watch For 2018

According to FT Partners, the FinTech market saw a record 412 financial deals during the third quarter of 2017. One of the largest deals in the quarter involved a $250 million investment by Softbank (OTCPK:SFTBY) in billion-dollar unicorn Kabbage (Private:KBGE).

Kabbage’s Offerings

Atlanta-based Kabbage was founded in 2008 by Kathryn Petralia, Rob Frohweins and Marc Gorlin, whom I had interviewed a few years ago. They pioneered the financial services data and technology platform to provide funding to small businesses almost instantly. Unlike traditional banks and moneylenders that rely on detailed financial business models, credit scores, and paperwork, Kabbage uses machine learning algorithms and takes into account data generated through business activity, including seller channels, social media, and shipping data, to analyze business performance. It does not call itself a lender, but a provider of merchant cash and working capital advances.

Based on these parameters, businesses can secure approved credit lines ranging from $2,000 to $150,000 within 10 minutes of the application process. Businesses can then borrow any amount once a day and pay interest on these borrowed amounts at borrowing fees that range from 1.5% to 10% per month. Loans are instantly available for periods up to six months and one year, with no penalty for early repayment. Kabbage also offers iOS- and Android-based apps that let users borrow funds on the go. It employs about 380 people.

Top 10 Heal Care Stocks To Watch For 2018: Globe Specialty Metals Inc.(GSM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Ferroglobe PLC (NASDAQ: GSM) got a boost, shooting up 10 percent to $10.17 after the company posted a narrower-than-expected Q1 loss.

    Puma Biotechnology Inc (NASDAQ: PBYI) shares were also up, gaining 37 percent to $51.75 as briefing documents for Wednesday Advisory Committee meeting are published to the FDA website. The documents showed that neratinib performed better than Roche's trastuzumab in I-SPY2 trial, particularly in subgroup of patients that were HRc negative. The briefing docs also showed that study 3004 met prespecified primary efficacy endpoint.

  • [By Dan Caplinger]

    But there are still plenty of factors that are preventing stocks overall from mounting stronger gains, including nervousness about geopolitical issues as well as weaker parts of the global economy. Nevertheless, some stocks posted strong gains, and Puma Biotechnology (NASDAQ:PBYI), Applied Optoelectronics (NASDAQ:AAOI), and Ferroglobe (NASDAQ:GSM) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

Top 10 Heal Care Stocks To Watch For 2018: Superior Energy Services Inc.(SPN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Thursday afternoon, energy shares slipped by just 0.1 percent. Meanwhile, top gainers in the sector included Superior Energy Services, Inc. (NYSE: SPN), and Yanzhou Coal Mining Co Ltd (ADR) (NYSE: YZC).

  • [By Lisa Levin]

    Tuesday afternoon, the energy shares slipped by just 0.2 percent. Meanwhile, top gainers in the sector included Willbros Group Inc (NYSE: WG), up 7 percent, and Superior Energy Services, Inc. (NYSE: SPN), up 6 percent.

  • [By Lisa Levin]

    Energy sector was the top gainer in the US market on Friday. Top gainers in the sector included Superior Energy Services, Inc. (NYSE: SPN), Panhandle Oil and Gas Inc. (NYSE: PHX), and SM Energy Co (NYSE: SM).

Top 10 Heal Care Stocks To Watch For 2018: Stage Stores, Inc.(SSI)

Advisors’ Opinion:

  • [By Paul Ausick]

    Stage Stores Inc. (NYSE: SSI) dropped nearly 20% on Monday to post a new 52-week low of $3.21 after closing at $4.00 on Friday. Volume was more than 5 times the daily average of about 650,000 shares. The company posted poor holiday season sales last Friday and lowered its guidance.

  • [By Lisa Levin]

    Stage Stores Inc (NYSE: SSI) was down, falling around 16 percent to $3.35 as the company reported a drop in its holiday season same-store sales and lowered its earnings guidance. The retailer’s same-store sales dropped 7.3 percent for the nine-week period ending December 31, 2016.

Top 10 Heal Care Stocks To Watch For 2018: Harmony Gold Mining Company Limited(HMY)

Advisors’ Opinion:

  • [By Javier Hasse]

    Harmony Gold Mining Co. (ADR) (NYSE: HMY) rose 2.2 percent on Friday, even though gold prices dropped. However, the stock lost 3.7 percent in after-hours trading, in what also seemed like a correction of the surge seen during the day.

  • [By Alex McGuire]

    This list ranks gold dividend stocks in the mining sector by dividend yield. And it also includes one of our top gold stock recommendations of 2017…

    Gold Dividend Stock Share Price Year-to-Date Performance Dividend Yield (as of June 30)
    DRDGOLD Ltd. (NYSE ADR: DRD) $3.19 -39.7% 10.24%
    Sibanye Gold Ltd. (NYSE ADR: SBGL) $4.70 -33.4% 5.98%
    Harmony Gold Mining Co. (NYSE ADR: HMY) $1.62 -26.7% 4.56%
    Gold Fields Limited (NYSE ADR: GFI) $3.41 +13.3% 2.73%
    Randgold Resources Ltd. (Nasdaq ADR: GOLD) $87.68 +14.9% 1.89%
    Franco Nevada Corp. (NYSE: FNV) $72.39 +21.1% 1.27%
    Royal Gold Inc. (Nasdaq: RGLD) $76.85 +21.3% 1.25%
    Eldorado Gold Corp. (NYSE: EGO) $2.58 -19.9% 1.16%
    Barrick Gold Corp. (NYSE: ABX) $15.90 -0.5% 0.75%
    Goldcorp Inc. (NYSE: GG) $13.02 -4.4% 0.62%

    Six of the 10 gold stocks listed above have posted negative returns so far in 2017. The main reason behind their losses has to do with gold price volatility.

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares fell by 0.73 percent. Meanwhile, top losers in the sector included Silver Wheaton Corp. (USA) (NYSE: SLW), down 5 percent, and Harmony Gold Mining Co. (ADR) (NYSE: HMY), down 5 percent.

Top 10 Heal Care Stocks To Watch For 2018: Radient Technologies (RTI)

Advisors’ Opinion:

  • [By Matthew Briar]

    There’s an old business adage…. it’s not so much what you know, but who you know. If that’ s truly the case (and it is), then shareholders in Radient Technologies Inc (CVE:RTI) should be elated. The newest member of the Board of Directors that not already knows a lot of the right people, but has pretty much done all of things Radient would like to accomplish in the near future. That is, he was on the board for another ingredient and chemical company that was eventually acquired, but he also holds a masters degree in engineering. He can do it all, understanding the art and science of the business.

    It’s yet another reason for RTI investors to be enthused.

    Radient Technologies isn’t exactly a new company, but it’s relative notoriety is a fairly new phenomenon.

    The organization, in simplest terms, has developed an ingredient-extraction process called microwave assisted processing, or “MAP,” for short. As the name implies, the use of radio microwaves helps the extraction process along.

    Using its patented MAP process, Radient is able to selectively deposit microwave energy into a biomass (source material) and heat the target elements while leaving other materials in the mix unaltered. The near-instantaneous “in-core” heating that occurs creates pressure which drives out the targeting ingredient or component much faster than more conventional extraction methods. In fact, the pressure-driven process outperforms the conventional extraction on pretty much every front. That is, the technique reduces the extraction time from hours to minutes, delivers a higher active ingredient purity, increases the recovery of actives from often scarce biomass, and uses much less solvent and energy than the more typical approach.

    The technique can, and already has, created natural ingredients for global customers across a range of industries, including food and beverage, nutrition, supplements, pharmaceuticals and cosmetics.

    The company’

  • [By James E. Brumley]

    Some of the stories about how cannabis has changed lives for the better are nothing less than astounding. Take Illinois resident Darren Miller as an example. In 2015 Miller was diagnosed with lung cancer that was later deemed terminal. Miller underwent chemotherapy, without much hope, but also began using high-THC Indica cannabis oil. Miller is alive today, and arguably shouldn’t be.

    Then there’s Floridian Branden Petro. Not only does Petro suffer epilepsy, he commonly experiences seizures stemming from the condition. Nothing has stopped the seizures as quickly or effectively as 200 milligram worth of THC cannabis oil, administered as a nasal spray. Within 20 seconds of using it, it’s as of the seizure never happened.

    And there are millions of other such (and less dramatic) examples, all pointing in the same direction – cannabis has medical value on multiple fronts. Not facilitating its commercialization is a wasted opportunity.

    It’s a notion that’s far from lost on the people that have built Canadian-based Radient Technologies Inc (CVE:RTI) from the round up, recently inking a deal with supplier of cannabinoid extracts, Aurora Cannabis.

    It’s a real accolade. Aurora is one of the largest licensed producers of medical cannabis under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR), and recently began construction on an unprecedented 800,000 square foot production facility in Leduc County, Alberta. This facility, known as “Aurora Sky”, is anticipated to be capable of producing in excess of 100,000 kg of high-quality, low-cost marijuana per year.

    In most regards though, Radient Technologies is the big winner of the deal, as the partnership is apt to put its high-tech facility in full demand, helping to advance the advent of cannabis in all its potential glory.

    It’s a rather amazing science, really. Radient Technologies uses an ingredient-extraction process called microwave assisted proc

  • [By Jim Robertson]

    Small cap Radient Technologies (CVE: RTI) is focused on extracting, isolating and purifying food/nutraceutical ingredients (colourings, flavourings, preservatives etc) and pharmaceutical raw materials from its20,000 square foot manufacturing plant in Edmonton, Alberta. The Companyworks with global brands across a range of industries (including Food and Beverage, Nutrition and Supplements, Pharmaceuticals, Personal Care and Cosmetics and Biofuel) andengageswithits clients in three distinct phases:

  • [By Jim Robertson]

    Shares of small cap natural compound and Cannabinoid extract stock Radient Technologies (CVE: RTI) have been taking off lately as the Company makes further progress commercializing its technology. The Company extracts natural compounds from a range of biological materials using microwave assisted processing (MAP), a patented technology platform which provides superior customer outcomes in terms of ingredient purity, yield and cost. This technology is based on the selective and localized heating of the moisture present in all natural materials using microwaves as the energy source. This gives the Company a technological advantage and expertise in selectively depositing microwave energy into different parts of a biomass’ complicated chemical system form the core of our extraction advantage.

  • [By Matthew Briar]

    Although the past several years have been very good ones for the cannabis — marijuana and hemp — industry, it’s still mostly being done in an old, artisan-style fashion. Most companies haven’t figured out a way of scaling up their outputs by improving their operating/production efficiency, even though the market’s growth has merited. Radient Technologies Inc (CVE:RTI) represents that next evolution of the cannabinoid business, introducing a new approach to extracting cannabinoids from cannabis plants that will not only improve yields, but create a superior, purer product.

    Canada-based Radient Technologies has developed — and patented – an ingredient-extraction process called microwave assisted processing, or “MAP,” for short. As the name implies, the use of radio microwaves helps the extraction process along. To fully appreciate why it matters, however, one has look at the approach other ingredients suppliers are utilizing now.

    With current approaches to create ingredients from an appropriate source, the material with the target compound or molecule in it is soaked in a solvent, heated to 50 degrees Celsius (or more), and over the course of several hours, the desired ingredient diffuses into the solvent. After filtration, drying, and other processing, that ingredient is finally isolated and then collected.

    It works, but it’s hardly ideal. Aside from the fact that this technique doesn’t work very well at large scale, yields are relatively low. Worse, a lot of things you don’t want to extract can still be found in the extract, lowering the quality and purity of the ingredient.

    Radient Technologies’ microwave assisted processing changes all of this.

    Using its patented MAP process, Radient is able to selectively deposit microwave energy into a biomass (source material) and heat the target elements while leaving other materials in the mix unaltered. The near-instantaneous “in-core” heating that occurs creates pressure which

Top 10 Heal Care Stocks To Watch For 2018: Northern Oil and Gas, Inc.(NOG)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, energy shares slipped by 1.36 percent. Meanwhile, top losers in the sector included Northern Oil & Gas, Inc. (NYSE: NOG), down 9 percent, and North American Energy Partners Inc.(USA) (NYSE: NOA), down 6 percent.

  • [By Lisa Levin]

    In trading on Friday, energy shares slipped by 0.20 percent. Meanwhile, top losers in the sector included Northern Oil & Gas, Inc. (NYSE: NOG), down 9 percent, and Tidewater Inc. (NYSE: TDW), down 8 percent.

  • [By Lisa Levin]

    In trading on Tuesday, energy shares were relative laggards, down on the day by about 0.57 percent. Meanwhile, top losers in the sector included Tesco Corporation (USA) (NASDAQ: TESO), down 7 percent, and Northern Oil & Gas, Inc. (NYSE: NOG), down 8 percent.

Top 10 Heal Care Stocks To Watch For 2018: B2Gold Corp(BTG)

Advisors’ Opinion:

  • [By Lisa Levin] Related CXW Trump Or Clinton: Who Would Create More Jobs? The 2016 Economics Nobel Prize Winner's Case Against Private Prisons: Contracts Are The Key Wall Street Breakfast: Trump Takes The White House (Seeking Alpha)
    Related SAEX 20 Biggest Mid-Day Losers For Friday 22 Stocks Moving In Friday's Pre-Market Session SAExploration wins $35M seismic data deal (Seeking Alpha)
    Gainers
    Corrections Corp Of America (NYSE: CXW) shares rose 16.3 percent to $16.50 in pre-market trading following Donald Trump's victory.
    SAExploration Holdings, Inc. (NASDAQ: SAEX) shares rose 15.4 percent to $7.26 in pre-market trading after the company reported a new $35 million deep water ocean-bottom marine project award.
    The GEO Group Inc (NYSE: GEO) shares rose 12.9 percent to $26.95 in pre-market trading following Donald Trump's victory.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 12.3 percent to $7.40 in pre-market trading after gaining 0.30 percent on Tuesday.
    Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) rose 11.7 percent to $10.35 in pre-market trading. Ariad Pharmaceuticals disclosed that its Phase 1/2 trial data on investigational drug brigatinib were published in The Lancet Oncology.
    AK Steel Holding Corporation (NYSE: AKS) rose 11.2 percent to $6.75 in pre-market trading after gaining 3.23 percent on Tuesday.
    Pretium Resources Inc (NYSE: PVG) rose 11 percent to $10.50 in pre-market trading after declining 1.66 percent on Tuesday.
    First Majestic Silver Corp (NYSE: AG) rose 9.3 percent to $8.90 in the pre-market trading session. First Majestic reported Q3 earnings of $0.07 per share on revenue of $79.3 million. Silver futures gained 2.2 percent to $18.77 an ounce.
    Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) rose 9.2 percent to
  • [By Peter Graham]

    The following mining companies are active in Burkina Faso:

    Semafo Inc (TSE: SMF; OTCMKTS: SEMFF).SEMAFO operates the Mana Mine in Burkina Faso, which includes the high-grade satellite deposit of Siou, and is targeting production start-up of the Boungou Mine in the second half of 2018. SEMAFO’s strategic focus is to maximize shareholder value by effectively managing its existing assets as well as pursuing organic and strategic growth opportunities. SEMAFOs Mana Mine is located 260 kilometers southwest of the capital Ouagadougou. The third-largest mine in the country, it has produced some 1.6 million ounces since its first gold pour in 2008. Since then,the Company hasexpanded the plant four times to a current processing rate of over 7,200 tonnes per day. IAMGOLD Corp (NYSE: IAG). Iamgold has four operating gold mines on three continents with asolid base of strategic assets in North and South America and West Africa that is complemented by development and exploration projects with continued assessment of accretive acquisition opportunities. Iamgold is said to be thelargest private employer in Burkina Faso andhas a high level of exposure in the region with two operating mines in Mali and a mine in northern Burkina Faso near the Mali border. Roxgold Inc (TSE: ROXG; OTCMKTS: ROGFF). Roxgold is a gold mining company with its key asset, the high grade Yaramoko Gold Mine, located in the Hound茅 greenstone region of Burkina Faso, West Africa. The Company declared commercial production on October 1, 2016. The Yaramoko permit covers approximately 196km2 in the Province of Bal茅 in southwestern Burkina Faso. The property is located approximately 200 kilometres southwest from the capital city of Ouagadougou. Yaramoko lies directly south of, and is contiguous to, the SEMAFO Inc property hosting its flagship Mana Gold Mine and lies within the Hounde greenstone belt. Endeavour Mining Corp (TSE: EDV; OTCMKTS: EDVMF). Endeavour is ideally positioned as the majo

  • [By Monica Gerson]

    B2Gold Corp (NYSE: BTG) is estimated to post its quarterly earnings at $0.00 per share on revenue of $135.84 million.

    Astro-Med, Inc. (NASDAQ: ALOT) is projected to post its quarterly earnings at $0.21 per share on revenue of $25.50 million.

Top 10 Heal Care Stocks To Watch For 2018: NanoString Technologies, Inc.(NSTG)

Advisors’ Opinion:

  • [By Lisa Levin]

    NanoString Technologies Inc (NASDAQ: NSTG) was down, falling around 21 percent to $18.06 after the company issued weak revenue forecast for FY2016.

Top 10 Heal Care Stocks To Watch For 2018: Sigma Designs, Inc.(SIGM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Sigma Designs Inc (NASDAQ: SIGM) shares dropped 30 percent to $5.43. Sigma Designs reported fiscal third-quarter net income of $221,000 on revenue of $62.7 million.

  • [By Paul Ausick]

    Sigma Designs Inc. (NASDAQ: SIGM) dropped about 34% on Wednesday to post a new 52-week low of $5.20 against a 52-week high of $8.60 and a Tuesday close of $7.75. Volume of about 6.2 million was about 25 times the daily average of around 280,000. The company reported so-so earnings on Tuesday and the stock was downgraded and price targets lowered by several analysts.

  • [By Lisa Levin]

    Gainers

    Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
    Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
    Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
    Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
    Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
    Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
    Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
    Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
    Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia

Top 10 Heal Care Stocks To Watch For 2018: Catabasis Pharmaceuticals, Inc.(CATB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Catabasis Pharmaceuticals Inc (NASDAQ: CATB) got a boost, shooting up 46 percent to $6.52. Catabasis Pharmaceuticals and Sarepta Therapeutics Inc (NASDAQ: SRPT) reported a joint research collaboration in Duchenne Muscular Dystrophy.